Swiss National Bank Cuts Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Swiss National Bank decreased its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 2.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 329,700 shares of the company’s stock after selling 6,700 shares during the period. Swiss National Bank owned about 0.20% of Option Care Health worth $11,523,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Public Employees Retirement System of Ohio raised its position in Option Care Health by 21.6% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock valued at $43,000 after purchasing an additional 332 shares in the last quarter. Johnson Financial Group Inc. bought a new position in shares of Option Care Health during the 4th quarter valued at about $47,000. Bessemer Group Inc. lifted its position in Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company’s stock worth $54,000 after buying an additional 599 shares during the last quarter. Wealthquest Corp purchased a new stake in Option Care Health in the first quarter worth approximately $66,000. Finally, Farther Finance Advisors LLC boosted its stake in Option Care Health by 434.8% in the first quarter. Farther Finance Advisors LLC now owns 1,920 shares of the company’s stock worth $67,000 after buying an additional 1,561 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Option Care Health Price Performance

OPCH stock opened at $28.41 on Friday. The stock has a market capitalization of $4.61 billion, a price-to-earnings ratio of 22.73, a PEG ratio of 1.80 and a beta of 0.79. The firm’s 50-day moving average price is $30.36 and its two-hundred day moving average price is $31.87. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%. The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.35 billion. During the same quarter in the previous year, the business earned $0.30 EPS. Option Care Health’s revenue was up 15.4% compared to the same quarter last year. As a group, equities analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Barrington Research restated an “outperform” rating and issued a $38.00 price objective on shares of Option Care Health in a report on Thursday, July 10th. JMP Securities boosted their price target on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “market outperform” rating in a research note on Thursday, July 31st. UBS Group upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their price target for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. Finally, Citigroup reiterated an “outperform” rating on shares of Option Care Health in a report on Thursday, July 31st. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $35.75.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.